| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | SKGE004B | |||
| Carrier Free | PKGE004B | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB4696-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-85802-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF6897-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73231 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76721-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76720-0.025mg | |||
![N/A VEGF [HRP]](http://images.novusbio.com/fullsize2/DATA_VEGF_DVE00_ELISA_871.jpg "N/A VEGF [HRP]")
![N/A VEGF [HRP]](http://images.novusbio.com/fullsize2/DATA_VEGF_DVE00_ELISA_872.jpg)
![N/A VEGF [HRP]](http://images.novusbio.com/fullsize2/VEGF_DVE00_ELISA_208.jpg)
![N/A CXCL8/IL-8 [HRP]](http://images.novusbio.com/fullsize2/DATA_CXCL8_IL8_D8050_ELISA_557.jpg "N/A CXCL8/IL-8 [HRP]")
![N/A CXCL8/IL-8 [HRP]](http://images.novusbio.com/fullsize2/DATA_CXCL8_IL8_D8050_ELISA_558.jpg)
![N/A CXCL8/IL-8 [HRP]](http://images.novusbio.com/fullsize2/CXCL8_D8000C_ELISA_378.jpg)
![Toll-like receptor 4 (TLR4) silencing decreases endogenous levels of pro-inflammatory cytokines. a Effect of TLR2/4 silencing in breast cancer cells transfected with negative control (nc) siRNA, or siRNA directed against TLR2 mRNA (si#1 and si#2) or TLR4 mRNA (si#1 and si#2) was analyzed using quantitative real-time PCR; ***P <0.001 (analysis of variance (ANOVA)). b IL-6 (left) and IL-8 (right) ELISA on supernatants from MDA-MB-231 breast cancer cells transfected with nc siRNA, or siRNA directed against TLR2 mRNA (si#1 and si#2) or TLR4 mRNA (si#1 and si#2); n = 4. Error bars standard error of the mean (SEM); *P <0.05, **P <0.01, ***P <0.001 (ANOVA). c Boyden chamber migration assays. Migration of primary human myeloid cells towards supernatants from different cell lines indicated. Human primary peripheral blood mononuclear cells were isolated as previously described [48] and allowed to migrate through a Costar Transwell® Permeable Support 8.0-μm 24-well plate (Corning) to the supernatants of breast cancer supernatants cultured under serum-free conditions. Percentage of migrated CD11b+ cells was analyzed using a flow cytometer and CD11b-APC antibodies (BD Sciences); n = 4. Error bars SEM; *P <0.05, **P <0.01, ***P <0.001 (ANOVA). d Matrigel invasion assays. Invasion of lipopolysaccharide (LPS)-stimulated/un-stimulated MDA-MB-231 cells into matrigel invasion chambers (BD Sciences) as indicated: 25 × 103 MDA-MB-231 cells were stimulated or not with LPS and allowed to invade from 72 h. Amount of invaded cells was analyzed using crystal violet staining and manual counting in four separate experiments; n = 4. Error bars SEM; *P <0.05, **P <0.01, ***P <0.001 (Student’s t test) Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26392082), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/d8000c_human-il-8-cxcl8-quantikine-elisa-kit-22820241795613.jpg)
![N/A Prostaglandin E2/PGE2 [Biotin]](http://images.novusbio.com/fullsize2/DATA_PGE2_KGE004_ELISA_906.jpg "N/A Prostaglandin E2/PGE2 [Biotin]")
![N/A Prostaglandin E2/PGE2 [Biotin]](http://images.novusbio.com/fullsize2/PGE2_KGE004_ELISA_406.jpg)
![Western Blot: PAK1 Antibody (4D1) [H00005058-M02] - Analysis of PAK1 expression in transfected 293T cell line by PAK1 monoclonal antibody (M02), clone 4D1.Lane 1: PAK1 transfected lysate (Predicted MW: 49.6 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/PAK1-Antibody-4D1-Western-Blot-H00005058-M02-img0011.jpg "Western Blot: PAK1 Antibody (4D1) [H00005058-M02] - Analysis of PAK1 expression in transfected 293T cell line by PAK1 monoclonal antibody (M02), clone 4D1.Lane 1: PAK1 transfected lysate (Predicted MW: 49.6 KDa).Lane 2: Non-transfected lysate.")
![Immunocytochemistry/Immunofluorescence: PAK1 Antibody (4D1) [H00005058-M02] - Analysis of monoclonal antibody to PAK1 on HeLa cell. Antibody concentration 35 ug/ml.](http://images.novusbio.com/fullsize/PAK1-Antibody-4D1-Immunocytochemistry-Immunofluorescence-H00005058-M02-img0006.jpg)
![Immunohistochemistry-Paraffin: PAK1 Antibody (4D1) [H00005058-M02] - Analysis of monoclonal antibody to PAK1 on formalin-fixed paraffin-embedded human stomach. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/PAK1-Antibody-4D1-Immunohistochemistry-Paraffin-H00005058-M02-img0008.jpg)
![Western Blot: PAK1 Antibody (4D1) [H00005058-M02] - Western Blot analysis of PAK1 expression in HeLa NE ( Cat # L013V3 ).](http://images.novusbio.com/fullsize/PAK1-Antibody-4D1-Western-Blot-H00005058-M02-img0001.jpg)
![Immunoprecipitation: PAK1 Antibody (4D1) [H00005058-M02] - Analysis of PAK1 transfected lysate using anti-PAK1 monoclonal antibody and Protein A Magnetic Bead, and immunoblotted with PAK1 monoclonal antibody.](http://images.novusbio.com/fullsize/PAK1-Antibody-4D1-Immunoprecipitation-H00005058-M02-img0009.jpg)
![Sandwich ELISA: PAK1 Antibody (4D1) [H00005058-M02] - Detection limit for recombinant GST tagged PAK1 is approximately 0.1ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/PAK1-Antibody-4D1-Sandwich-ELISA-H00005058-M02-img0010.jpg)
![Western Blot: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PAK4.](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Western-Blot-NBP2-46316-img0013.jpg "Western Blot: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PAK4.")
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0012.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0001.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Adenocarcinoma of Human colon. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0002.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0003.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Human lung tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0004.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Carcinoma of Human lung tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0005.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0006.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0007.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0008.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0009.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Human prostate tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0010.jpg)
![Immunohistochemistry: PAK4 Antibody (1C7) [NBP2-46316] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/PAK4-Antibody-1C7-Immunohistochemistry-NBP2-46316-img0011.jpg)
![Immunohistochemistry-Paraffin: PAK1 Antibody [NBP2-19680] - Paraffin-embedded mouse fore brain. PAK1 antibody [N2C2], Internal dilution: 1:500.](http://images.novusbio.com/fullsize/PAK1-Antibody-Immunohistochemistry-Paraffin-NBP2-19680-img0006.jpg "Immunohistochemistry-Paraffin: PAK1 Antibody [NBP2-19680] - Paraffin-embedded mouse fore brain. PAK1 antibody [N2C2], Internal dilution: 1:500.")
![Western Blot: PAK1 Antibody [NBP2-19680] - Sample (30 ug of whole cell lysate) A: A431 7. 5% SDS PAGE gel, diluted at 1:5000.](http://images.novusbio.com/fullsize/PAK1-Antibody-Western-Blot-NBP2-19680-img0001.jpg)
![Western Blot: PAK1 Antibody [NBP2-19680] - Sample (30 ug of whole cell lysate) A: BCL-1 7. 5% SDS PAGE gel, diluted at 1:10000.](http://images.novusbio.com/fullsize/PAK1-Antibody-Western-Blot-NBP2-19680-img0002.jpg)
![Immunohistochemistry-Paraffin: PAK1 Antibody [NBP2-19680] - HBL435 xenograft.](http://images.novusbio.com/fullsize/PAK1-Antibody-Immunohistochemistry-Paraffin-NBP2-19680-img0004.jpg)
![PAK1 antibody [N2C2], Internal detects PAK1 protein by western blot analysis.A. 30 ug PC-12 whole cell lysate/extract7.5% SDS-PAGEPAK1 antibody [N2C2], Internal (NBP2-19680) dilution: 1:1000 The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-19680_rabbit-polyclonal-pak1-antibody-western-blot-261120251819368.jpg)
![Western Blot: PAK2 Antibody - BSA Free [NBP1-76721] - Validation in Mouse TissuesLoading: 15 ug of lysates per lane.Antibodies: PAK2 (1 ug/mL per lane), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/nbp1-76721_rabbit-polyclonal-pak2-antibody-271120241937750.gif "Western Blot: PAK2 Antibody - BSA Free [NBP1-76721] - Validation in Mouse TissuesLoading: 15 ug of lysates per lane.Antibodies: PAK2 (1 ug/mL per lane), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![Immunohistochemistry: PAK2 Antibody - BSA Free [NBP1-76721] - Validation of PAK2 in Mouse Spleen Tissue. Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti-PAK2 antibody at 10 ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-76721_rabbit-polyclonal-pak2-antibody-2711202420175118.jpg)
![Immunocytochemistry/ Immunofluorescence: PAK2 Antibody - BSA Free [NBP1-76721] - Validation of PAK2 in Mouse Spleen TissueImmunofluorescent analysis of 4% paraformaldehyde-fixed mouse spleen tissue labeling PAK2 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).](http://images.novusbio.com/fullsize/nbp1-76721_rabbit-polyclonal-pak2-antibody-271120242013190.jpg)
![Western Blot: PAK2 Antibody - BSA Free [NBP1-76721] - Validation in Jurkat LysateLoading: 15 ug of lysates per lane.Antibodies: PAK2 (A: 0.5 ug/mL, B: 1 ug/mL and C: 2 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/nbp1-76721_rabbit-polyclonal-pak2-antibody-2711202420195369.jpg)
![<b>Independent Antibodies Validation. </b>Western Blot: PAK2 Antibody [NBP1-76721] - Validation (IAV) via Protein Expression Profile in Cell Lines.Loading: 15 ug of lysates per lane. Antibodies: PAK2 NBP1-76720 (1 ug/mL), PAK2 NBP1-76721 (1 ug/mL) and beta-actin (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/PAK2-Antibody-Western-Blot-NBP1-76721-img0004.jpg)
![Western Blot: PAK2 Antibody - BSA Free [NBP1-76721] - Validation in Human Cell Lines. Loading: 15 ug of lysates per lane.Antibodies: PAK2 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/nbp1-76721_rabbit-polyclonal-pak2-antibody-2711202420414582.gif)
![Western Blot: PAK2 Antibody [NBP1-76720] - Western Blot Validation in Mouse Tissues. Loading: 15 ug of lysates per lane. Antibodies: PAK2 NBP1-76720 (1 ug/mL per lane), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/PAK2-Antibody-Western-Blot-NBP1-76720-img0007.jpg "Western Blot: PAK2 Antibody [NBP1-76720] - Western Blot Validation in Mouse Tissues. Loading: 15 ug of lysates per lane. Antibodies: PAK2 NBP1-76720 (1 ug/mL per lane), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![Western Blot: PAK2 Antibody [NBP1-76720] - Analysis of PAK2 in rat bladder tissue lysate with PAK2 antibody at (A) 0.5 and (B) 1 ug/mL.](http://images.novusbio.com/fullsize/PAK2-Antibody-Western-Blot-NBP1-76720-img0004.jpg)
![<b>Independent Antibodies Validation. </b>Western Blot: PAK2 Antibody [NBP1-76720] - Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines.Loading: 15 ug of lysates per lane. Antibodies: PAK2 NBP1-76720 (1 ug/mL), PAK2 NBP1-76721 (1 ug/mL) and beta-actin (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/PAK2-Antibody-Western-Blot-NBP1-76720-img0005.jpg)
![Western Blot: PAK2 Antibody [NBP1-76720] - Western Blot Validation in Human, Mouse and Rat Cell Lines. Loading: 15 ug of lysates per lane. Antibodies: PAK2 NBP1-76720 (1 ug/mL per lane), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000dilution](http://images.novusbio.com/fullsize/PAK2-Antibody-Western-Blot-NBP1-76720-img0006.jpg)
![Immunohistochemistry: PAK2 Antibody - BSA Free [NBP1-76720] - Figure 5 Immunohistochemistry Validation of PAK2 in Mouse Spleen Tissue Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti-PAK2 antibody at 10 u/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-76720_rabbit-polyclonal-pak2-antibody-2711202420333831.jpg)
![Immunocytochemistry/ Immunofluorescence: PAK2 Antibody - BSA Free [NBP1-76720] - Validation of PAK2 in Mouse Spleen Cells. Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse spleen labeling PAK2 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).](http://images.novusbio.com/fullsize/nbp1-76720_rabbit-polyclonal-pak2-antibody-2711202420171757.jpg)